A simple addition to injected COVID-19 vaccines could enhance their effectiveness and provide "border protection" immunity in areas like the nose and mouth to supplement antibodies in the bloodstream, new research suggests.
Aug 11, 2021
0
382
(HealthDay)—Polygenic variants are associated with comparable risk for developing open-angle glaucoma as that associated with the most common single-gene pathogenic variant, according to a study published online July 15 ...
Jul 23, 2021
0
2
The World Health Organization on Wednesday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on COVID-19 vaccines was not a bid to "snatch" their intellecutual property rights.
Jul 22, 2021
0
1
In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
May 26, 2021
0
326
The European Parliament has urged the EU to back a push for a temporary waiver of coronavirus vaccine patents, in the face of scepticism from Brussels and key member states.
May 20, 2021
0
9
DEAR MAYO CLINIC: I'm 36 and do not have any significant medical concerns, but due to a family member's heart health issues, it was recommended I have a cardiac evaluation. After undergoing an echocardiogram, I was surprised ...
May 12, 2021
0
3
While the U.S. president is calling for suspending patents on COVID-19 vaccines, experts at UNESCO are quietly working on a more ambitious plan: a new global system for sharing scientific knowledge that would outlast the ...
May 11, 2021
0
3
New COVID-19 deaths surged past 4,000 for the first time in India on Saturday in one of the world's worst outbreaks, as EU pressure mounted on Washington to end vaccine export limits and offer a concrete plan to lift patents.
May 8, 2021
0
2
German Chancellor Angela Merkel on Saturday urged the United States to export coronavirus vaccines made on its soil, as she rejected a patent waiver call from Washington for the jabs.
May 8, 2021
0
3
European Union leaders cranked up their criticism of the U.S. call to waive COVID-19 vaccine patents Saturday, arguing the move would yield no short-term or intermediate improvement in vaccine supplies and could even have ...
May 8, 2021
1
3
